Organization
Chengdu Brilliant Pharmaceutical
2 clinical trials
Clinical trial
A Multicenter, Randomized, Open-label and Parallel-controlled Phase III Study to Compare the Efficacy and Safety of Semaglutide Injection With Ozempic® in the Treatment of Type 2 Diabetes Subjects With Poor Glycemic Control on MetforminStatus: Not yet recruiting, Estimated PCD: 2025-08-30
Clinical trial
A Multicenter, Randomized, Double-blind Clinical Trial to Evaluate the Efficacy and Safety of BT-KTM-I Versus Ketanest® S for General Anesthesia in Elective Laparoscopic SurgeryStatus: Not yet recruiting, Estimated PCD: 2024-01-01